CegedimXPAR:ALCGM +0.57%81 Net Margin % is 2.52% as of Dec. 2025, which is 88% above its 10-year median of 1.34. GuruFocus rates XPAR:ALCGM with a GF Score™ of 81/100 and a GF Value™ of €12.80 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Cegedim ranks worse than 57.38% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Cegedim's Net Income for the
six
months ended in Dec. 2025 was €8.2 Mil. Cegedim's Revenue for the
six
months ended in Dec. 2025 was €326.7 Mil. Therefore, Cegedim's net margin for the quarter that ended in Dec. 2025 was 2.52%.
The historical rank and industry rank for Cegedim's Net Margin % or its related term are showing as below:
XPAR:ALCGM'
s Net Margin % Range Over the Past 10 Years
Min: -6.23 Med: 1.34 Max: 5
Current: 1.45
XPAR:ALCGM's Net Margin % is ranked worse than 57.38% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs XPAR:ALCGM: 1.45
Cegedim (XPAR:ALCGM) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Cegedim Net Margin % Related Terms
Cegedim Net Margin % Historical Data
* Premium members only.
The historical data trend for Cegedim's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALCGM vs VEEV, BTSG, TEM: Net Margin % Comparison
For the Health Information Services subindustry, Cegedim's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cegedim Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cegedim's Net Margin % distribution charts can be found below:
* The bar in red indicates where Cegedim's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cegedim (XPAR:ALCGM) has a Net Margin % of 2.52% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Cegedim and its competitors. This is 88% above median its historical median of 1.34. According to the industry distribution chart, Cegedim ranks #381 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 57.4%.
Is Cegedim's Net Margin % too high?
Cegedim's current Net Margin % of 2.52% is 88% above median its 10-year median of 1.34. The Healthcare Providers & Services industry median Net Margin % is 2.92. Cegedim's value of 2.52% is 13.6% below this industry median. Based on the distribution chart, Cegedim ranks #381 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cegedim has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cegedim's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cegedim ranks #381 out of 664 companies for Net Margin %. This places Cegedim in the lower half of its industry. The industry median Net Margin % is 2.92. Cegedim's value of 2.52% is 13.6% below this benchmark. While the company's 10-year median is 1.34 vs. the industry median of 2.92, Cegedim has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cegedim's current Net Margin % of 2.52% is 13.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Cegedim and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cegedim's current Net Margin % is 2.52%, which is 88% above median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cegedim stock overvalued right now?
Based on GuruFocus' analysis, Cegedim (XPAR:ALCGM) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.80, compared to a current price of €10.54 — trading 17.7% below its estimated fair value. The current Net Margin % is 2.52%, which is 88% above median its 10-year median of 1.34 and 13.6% below the Healthcare Providers & Services industry median of 2.92. Cegedim's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Cegedim (XPAR:ALCGM), the current Net Margin % is 2.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cegedim (XPAR:ALCGM) Overvalued in 2026?
Based on GuruFocus' analysis, Cegedim stock appears to be undervalued.
The current stock price of €10.54 is trading 17.7% below its estimated GF Value™ of €12.80.
GuruFocus considers Cegedim to be Modestly Undervalued.
Key valuation signals for XPAR:ALCGM:
Net Margin %: 2.52% (88% above median its 10-year median of 1.34)
GF Value™: €12.80 vs. price of €10.54 (17.7% below fair value)
Industry Position: 13.6% below the Healthcare Providers & Services median (#381 of 664)
No single metric tells the full story. See the XPAR:ALCGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cegedim SA is a technology and services company offering digital flows of the healthcare ecosystem and B2B marketing, design of enterprise software for healthcare and insurance professionals. It is also engaged in human resources management and digitization. The company has two operating segments namely, Health insurance, HR and e-services; and Healthcare Professionals. Cegedim generates most of its revenue from France. The company's services include insurers solutions, promotional information, sales statistics of pharmaceutical products and digital promotion for healthcare companies.
81GF Score
Get the complete analysis for XPAR:ALCGM
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALCGM has been successfully added to your 
